Tag: Pfizer
How to Participate or Opt-Out of the Pending EpiPen Class-Action Lawsuit
Know your options and take action if necessary.
FDA Warns of Possible Malfunctions for EpiPen, EpiPen Jr, and Mylan’s...
Devices may potentially have delayed injection or be prevented from properly injecting.
Ruling Allows Millions to Join Lawsuit in EpiPen Racketeering Case
US District Judge Daniel Crabtree ruled numerous lawsuits against the marketer and manufacturer of EpiPen may proceed as a nationwide class-action under a federal racketeering statute.
Critical Shortage Forces Australians to Rely on Contaminated and Expired EpiPens
The devices are intended as an emergency treatment for young children who suffer anaphylaxis, a life-threatening allergic reaction.
A Guide to Emergency Epinephrine Options in the US (Including Usage...
Emergency Epinephrine Options in the US including usage videos and links to savings programs.
The Future of EpiPen in Light of the Mylan-Pfizer Deal
An extension to the merger is being contemplated that would consolidate all aspects of the EpiPen business under one company.
Mylan, Marketer of EpiPen, to be Combined with Pfizer's Generics Business
Both companies are subject of a suit alleging an illegal scheme to increase sales of EpiPen.
Listen: Senator Chuck Schumer Demands Airlines Keep Stock Epinephrine Onboard
Schumer called on the FAA to lift an exemption that allows airlines to forgo keeping epinephrine onboard.
Epipen Supply Status Update and Extension of Expiration Dates
Tighter supplies and greater variability in pharmacy-level access will potentially continue through the summer months as seasonal demand increases.
Epinephrine Auto-Injector Companies Swept Up in 44 State Price Fixing Lawsuit
State prosecutors describe a price fixing scheme involving more than a dozen companies and as many executives responsible for sales, marketing, and pricing.
